Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers‐Danlos syndrome, hypermobility type
Marco Castori(Casa Sollievo della Sofferenza), Marina Colombi(University of Brescia), Arianna Zanca(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Nicola Chiarelli(University of Brescia), Marina Venturini(University of Brescia), Piergiacomo Calzavara‐Pinton(University of Brescia), Isabella Sperduti(San Gallicano Hospital), Chiara Dordoni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Paola Grammatico, Michele Valiante(Carlo Forlanini Hospital), Silvia Morlino, Marco Ritelli(University of Brescia), Claudia Celletti(Policlinico Umberto I), Filippo Camerota(Policlinico Umberto I)
American Journal of Medical Genetics Part C Seminars in Medical Genetics
February 5, 2015
Cited by 37
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
A framework for the classification of joint hypermobility and related conditions
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|597
Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|482
Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome
|Nature Genetics|2006|402
Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
|Nature Genetics|2012|244